跨界和新发疾病 SCIE

期刊简介预计审稿时间： 较慢,18-36周

Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):

Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.

Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.

Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.

Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).

Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.

《跨界和新兴疾病》汇集了对全球动物和人类造成最大经济威胁的传染病的最新研究成果。该期刊为全球有关其诊断、预防和管理的研究提供了一个平台，也为有关公共卫生、发病机制、流行病学、统计建模、诊断、生物安全问题、基因组学、疫苗开发和新疫情快速通报的论文提供了一个平台。论文应包括使用最先进技术的及时研究方法。编辑鼓励论文采用基于科学的方法研究影响这些疾病造成的生物安全威胁管理的社会经济和环境因素，包括风险分析和疾病传播建模。将优先考虑以控制跨界和新兴疾病的新型科学方法为重点的通信。以下主题通常被认为超出范围，但会根据具体情况做出决定（例如，对隐蔽野生动物种群的研究和对潜在物种灭绝的研究）：

病原体发现：在特定国家新发现的常见病原体，或一种新的病原体或基因序列，关于其出现或传播的背景或见解很少。

基于调查（而非纵向）方法的患病率估计调查和风险因素研究，除非此类研究是独一无二的。知识、态度和实践调查在范围内。

如果没有从实地研究中获得可靠的敏感性和特异性估计，则进行诊断测试开发。

仅关注实验室方法的研究，其中与疾病出现和传播的相关性不明显或无法推断（“纯研究”类型的研究）。

不会产生新知识的叙述性文献综述。系统评价和范围评价以及荟萃分析均在范围内。

《Transboundary And Emerging Diseases》(跨界和新发疾病)编辑部通讯方式为WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。